HomeCompareYSPY vs ARCC

YSPY vs ARCC: Dividend Comparison 2026

YSPY yields 63.58% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YSPY wins by $750.7K in total portfolio value
10 years
YSPY
YSPY
● Live price
63.58%
Share price
$14.76
Annual div
$9.38
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$775.3K
Annual income
$189,366.42
Full YSPY calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — YSPY vs ARCC

📍 YSPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYSPYARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YSPY + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YSPY pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YSPY
Annual income on $10K today (after 15% tax)
$5,404.16/yr
After 10yr DRIP, annual income (after tax)
$160,961.46/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, YSPY beats the other by $160,960.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YSPY + ARCC for your $10,000?

YSPY: 50%ARCC: 50%
100% ARCC50/50100% YSPY
Portfolio after 10yr
$399.9K
Annual income
$94,683.79/yr
Blended yield
23.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

YSPY
No analyst data
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YSPY buys
0
ARCC buys
0
No recent congressional trades found for YSPY or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYSPYARCC
Forward yield63.58%10.82%
Annual dividend / share$9.38$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$775.3K$24.5K
Annual income after 10y$189,366.42$1.16
Total dividends collected$649.8K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: YSPY vs ARCC ($10,000, DRIP)

YearYSPY PortfolioYSPY Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$17,058$6,357.83$11,381$541.15+$5.7KYSPY
2$28,387$10,135.59$12,621$284.08+$15.8KYSPY
3$46,139$15,764.06$13,827$145.31+$32.3KYSPY
4$73,314$23,945.43$15,062$73.43+$58.3KYSPY
5$114,006$35,559.83$16,364$36.89+$97.6KYSPY
6$173,665$51,679.26$17,757$18.49+$155.9KYSPY
7$259,395$73,573.14$19,258$9.25+$240.1KYSPY
8$380,256$102,703.24$20,880$4.63+$359.4KYSPY
9$547,580$140,706.68$22,636$2.32+$524.9KYSPY
10$775,277$189,366.42$24,539$1.16+$750.7KYSPY

YSPY vs ARCC: Complete Analysis 2026

YSPYStock

The Fund’s primary investment objective is to achieve 3 times (300%) the income generated from selling options on S&P 500 Index. (NASDAQ SPY) (the “Underlying Stock”) by selling options on leveraged exchange-traded funds designed to deliver 3 times (300%) the daily performance of the Underlying Stock (the “Underlying Leveraged ETF”). The Fund’s secondary investment objective is to gain exposure to the performance of the Underlying Leveraged ETF, subject to a cap on potential investment gains. A downside protection may be implemented which could affect the net income level.

Full YSPY Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this YSPY vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YSPY vs SCHDYSPY vs JEPIYSPY vs OYSPY vs KOYSPY vs MAINYSPY vs HTGCYSPY vs GBDCYSPY vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.